Literature DB >> 8806749

Characterization of alpha 2-macroglobulin binding to human trabecular meshwork cells: presence of the alpha 2-macroglobulin signaling receptor.

G C Howard1, B C Roberts, D L Epstein, S V Pizzo.   

Abstract

Direct binding of receptor-recognized alpha 2-macroglobulin (alpha 2M*) or a cloned receptor binding fragment from rat alpha 1-macroglobulin (RBF) to human trabecular meshwork cells demonstrated two classes of cell surface binding sites. One class has an apparent Kd of 5.0 nM and a receptor number of 31,800 receptors/cell. The other class has an apparent Kd of 20 pM and a receptor number of 1600 receptors/cell. Binding studies of alpha 2M* or RBF in the presence of a competitor for binding to low-density-lipoprotein receptor-related protein/alpha 2M* receptor (LRP/alpha 2MR) called receptor-associated protein (RAP) show that only the lower affinity class of binding sites is susceptible to competition with RAP. Uptake studies demonstrate specific internalization and degradation of alpha 2M* which is inhibitable by RAP. Exposure of the cells to alpha 2M* and RBF (40 nM) is associated with mean increases of 171 and 210%, respectively, in the intracellular calcium concentration, which is not inhibitable by RAP or pertussis toxin. These studies present the first characterization of alpha 2M* and RBF signaling in a primary human cell type and suggest a role for alpha 2M* in the physiology of the eye.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806749     DOI: 10.1006/abbi.1996.0359

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Common actions of adenosine receptor agonists in modulating human trabecular meshwork cell transport.

Authors:  J C Fleischhauer; C H Mitchell; W D Stamer; M O Karl; K Peterson-Yantorno; M M Civan
Journal:  J Membr Biol       Date:  2003-05-15       Impact factor: 1.843

2.  Cell-specific differential modulation of human trabecular meshwork cells by selective adenosine receptor agonists.

Authors:  Mike O Karl; Kim Peterson-Yantorno; Mortimer M Civan
Journal:  Exp Eye Res       Date:  2006-10-30       Impact factor: 3.467

3.  The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors.

Authors:  B J Bacskai; M Q Xia; D K Strickland; G W Rebeck; B T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

4.  Characterization of the interaction between alpha2-macroglobulin and fibroblast growth factor-2: the role of hydrophobic interactions.

Authors:  Smitha Mathew; Sanja Arandjelovic; Wayne F Beyer; Steven L Gonias; Salvatore V Pizzo
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

5.  BKCa channel regulates calcium oscillations induced by alpha-2-macroglobulin in human myometrial smooth muscle cells.

Authors:  Monali Wakle-Prabagaran; Ramón A Lorca; Xiaofeng Ma; Susan J Stamnes; Chinwendu Amazu; Jordy J Hsiao; Celeste M Karch; Krzysztof L Hyrc; Michael E Wright; Sarah K England
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-04       Impact factor: 11.205

6.  Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity.

Authors:  Izumi Maezawa; Snjezana Zaja-Milatovic; Dejan Milatovic; Christina Stephen; Izabela Sokal; Nobuyo Maeda; Thomas J Montine; Kathleen S Montine
Journal:  J Neuroinflammation       Date:  2006-08-25       Impact factor: 8.322

7.  Biomechanical, ultrastructural, and electrophysiological characterization of the non-human primate experimental glaucoma model.

Authors:  VijayKrishna Raghunathan; J Seth Eaton; Brian J Christian; Joshua T Morgan; James N Ver Hoeve; Chen-Yuan Charlie Yang; Haiyan Gong; Carol A Rasmussen; Paul E Miller; Paul Russell; T Michael Nork; Christopher J Murphy
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

8.  Tissue plasminogen activator rescues steroid-induced outflow facility reduction via non-enzymatic action.

Authors:  Sofya Gindina; Arturo O Barron; Yan Hu; Antonios Dimopoulos; John Danias
Journal:  Mol Vis       Date:  2021-12-07       Impact factor: 2.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.